Skip to main navigation Skip to search Skip to main content

SONDERSTELLUNG DER SERONEGATIVEN CHRONISCHEN POLYARTHRITIS? KLINISCHES, BIOCHEMISCHES UND IMMUNGENETISCHES PROFIL DER FRUHEN SERONEGATIVEN UND SEROPOSITIVEN CHRONISCHEN POLYARTHRITIS

Translated title of the contribution: Does seronegative rheumatoid arthritis hold a special place? Clinical, biochemical and immunogenetic profile of early seronegative and seropositive cases of rheumatoid arthritis

H. H. Raspe, A. Vorbeck, M. Robin-Winn

Abstract

In the framework of an early-diagnosis out-patients clinic 100 patients (mean age 51 years), 82 of them female, were identified as highly suspicious of having chronic rheumatoid arthritis of recent onset (2-12 months). Five or more ARA criteria were present in 77 patients. IgM rheumatic factor was present in serum of 51 patients (latex fixation test). A Waaler-Rose test of ≥ 32 IU/ml was present in 21. After adjusting for α errors, there was a significantly higher prevalence of HLA-DR4 among those seropositive in the latex fixation test (64 vs 29%). A further 19 constitutional, anamnestic, clinical, biochemical and psychosocial criteria failed to reveal any different distribution between seropositive and seronegative cases. Using the specific definition of seropositivity in the Waaler-Rose test eliminated HLA-DR4 differences. The latter did not serve as a distinguishing criterion. There was only a marginal difference between DR4-positive and negative patients. These results fail to lend support to recent views of a special position of seronegative chronic rheumatoid arthritis.

Translated title of the contributionDoes seronegative rheumatoid arthritis hold a special place? Clinical, biochemical and immunogenetic profile of early seronegative and seropositive cases of rheumatoid arthritis
Original languageGerman
JournalDeutsche Medizinische Wochenschrift
Volume111
Issue number39
Pages (from-to)1474-1478
Number of pages5
ISSN0012-0472
DOIs
Publication statusPublished - 1986

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Does seronegative rheumatoid arthritis hold a special place? Clinical, biochemical and immunogenetic profile of early seronegative and seropositive cases of rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this